Schedule 13G/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G/A
Amendment No. 1
Under the Securities Exchange Act of 1934*
--------------------------------------------------------------------------------
China Biologic Products, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.0001 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
16938C106
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2008
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 (the "Act") or otherwise subject to the liabilities of that section of the
Act, but shall be subject to all other provisions of the Act (however, see the
Notes).
-------------------------------------------------------------------------------------------------------------------
CUSIP No. 16938C106
----------------------- -----------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities
only)
Jayhawk Private Equity Fund, L.P. (20-5004931)
----------------------- -----------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
----------------------- -----------------------------------------------------------------------------------------------
3 SEC USE ONLY
----------------------- -----------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
----------------------- -------------- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES
BENEFICIALLY OWNED BY 0
EACH REPORTING PERSON
WITH:
-------------- --------------------------------------------------------------------------------
6 SHARED VOTING POWER
1,498,700
-------------- --------------------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-------------- --------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,498,700
----------------------- -----------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,498,700 * (see Item 4)
----------------------- -----------------------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions) [ ]
Not Applicable
----------------------- -----------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.7%**
----------------------- -----------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
----------------------- -----------------------------------------------------------------------------------------------
* Includes 1,010,581 shares of common stock, par value $0.0001 per share, and
448,119 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report.
** Based on 21,434,942 outstanding shares of common stock, par value $0.0001 per
share, as reported by China Biologic Products, Inc. on its Form 10-Q for the
period ended September 30, 2008 filed with the Securities and Exchange
Commission on November 12, 2008.
1
-------------------------------------------------------------------------------------------------------------------
CUSIP No. 16938C106
----------------------- -----------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities
only)
Jayhawk Private Equity Co-Invest Fund, L.P. (20-5249125)
----------------------- -----------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
----------------------- -----------------------------------------------------------------------------------------------
3 SEC USE ONLY
----------------------- -----------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
----------------------- -------------- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES
BENEFICIALLY OWNED BY 0
EACH REPORTING PERSON
WITH:
-------------- --------------------------------------------------------------------------------
6 SHARED VOTING POWER
91,842
-------------- --------------------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-------------- --------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
91,842
----------------------- -------------- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
91,842* (see Item 4)
----------------------- -----------------------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions) [ ]
Not Applicable
----------------------- -----------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.4%**
----------------------- -----------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
----------------------- -----------------------------------------------------------------------------------------------
* Includes 63,628 shares of common stock, par value $0.0001 per share, and
28,214 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report.
** Based on 21,434,942 outstanding shares of common stock, par value $0.0001 per
share, as reported by China Biologic Products, Inc. on its Form 10-Q for the
period ended September 30, 2008 filed with the Securities and Exchange
Commission on November 12, 2008.
-------------------------------------------------------------------------------------------------------------------
2
CUSIP No. 16938C106
-------------------------------------------------------------------------------------------------------------------
----------------------- -----------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities
only)
Jayhawk Private Equity GP, L.P. (20-5005219)
----------------------- -----------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
----------------------- -----------------------------------------------------------------------------------------------
3 SEC USE ONLY
----------------------- -----------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
----------------------- -------------- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES
BENEFICIALLY OWNED BY 0
EACH REPORTING PERSON
WITH:
-------------- --------------------------------------------------------------------------------
6 SHARED VOTING POWER
1,550,542
-------------- --------------------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-------------- --------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,550,542
----------------------- -----------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,550,542 * (see Item 4)
----------------------- -----------------------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions) [ ]
Not Applicable
----------------------- -----------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%**
----------------------- -----------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
----------------------- -----------------------------------------------------------------------------------------------
* Includes 1,010,581 shares of common stock, par value $0.0001 per share, and
448,119 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report held by the Jayhawk Private Equity Fund, L.P. and
63,628 shares of common stock, par value $0.0001 per share, and 28,214 warrants
to purchase common stock that are exercisable within 60 days of the filing of
this report held by the Jayhawk Private Equity Co-Invest Fund, L.P.
** Based on 21,434,942 outstanding shares of common stock, par value $0.0001 per
share, as reported by China Biologic Products, Inc. on its Form 10-Q for the
period ended September 30, 2008 filed with the Securities and Exchange
Commission on November 12, 2008.
3
-------------------------------------------------------------------------------------------------------------------
CUSIP No. 16938C106
-------------------------------------------------------------------------------------------------------------------
----------------------- -----------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities
only)
Jayhawk Capital Management, L.L.C. (48-1172612)
----------------------- -----------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
----------------------- -----------------------------------------------------------------------------------------------
3 SEC USE ONLY
----------------------- -----------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
----------------------- -------------- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES
BENEFICIALLY OWNED BY 0
EACH REPORTING PERSON
WITH:
-------------- --------------------------------------------------------------------------------
6 SHARED VOTING POWER
1,550,542
-------------- --------------------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-------------- --------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,550,542
----------------------- -----------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,550,542 * (see Item 4)
----------------------- -----------------------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions) [ ]
Not Applicable
----------------------- -----------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%**
----------------------- -----------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
OO
----------------------- -----------------------------------------------------------------------------------------------
* Includes 1,010,581 shares of common stock, par value $0.0001 per share, and
448,119 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report held by the Jayhawk Private Equity Fund, L.P. and
63,628 shares of common stock, par value $0.0001 per share, and 28,214 warrants
to purchase common stock that are exercisable within 60 days of the filing of
this report held by the Jayhawk Private Equity Co-Invest Fund, L.P.
** Based on 21,434,942 outstanding shares of common stock, par value $0.0001 per
share, as reported by China Biologic Products, Inc. on its Form 10-Q for the
period ended September 30, 2008 filed with the Securities and Exchange
Commission on November 12, 2008.
4
-------------------------------------------------------------------------------------------------------------------
CUSIP No. 16938C106
-------------------------------------------------------------------------------------------------------------------
----------------------- -----------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities
only)
Kent C. McCarthy
----------------------- -----------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
----------------------- -----------------------------------------------------------------------------------------------
3 SEC USE ONLY
----------------------- -----------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
----------------------- -------------- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF SHARES
BENEFICIALLY OWNED BY 0
EACH REPORTING PERSON
WITH:
-------------- --------------------------------------------------------------------------------
6 SHARED VOTING POWER
1,550,542
-------------- --------------------------------------------------------------------------------
7 SOLE DISPOSITIVE POWER
0
-------------- --------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
1,550,542
----------------------- -----------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,550,542 * (see Item 4)
----------------------- -----------------------------------------------------------------------------------------------
10 CHECK IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES (See Instructions) [ ]
Not Applicable
----------------------- -----------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.1%**
----------------------- -----------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
----------------------- -----------------------------------------------------------------------------------------------
* Includes 1,010,581 shares of common stock, par value $0.0001 per share, and
448,119 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report held by the Jayhawk Private Equity Fund, L.P. and
63,628 shares of common stock, par value $0.0001 per share, and 28,214 warrants
to purchase common stock that are exercisable within 60 days of the filing of
this report held by the Jayhawk Private Equity Co-Invest Fund, L.P.
** Based on 21,434,942 outstanding shares of common stock, par value $0.0001 per
share, as reported by China Biologic Products, Inc. on its Form 10-Q for the
period ended September 30, 2008 filed with the Securities and Exchange
Commission on November 12, 2008.
5
Item 4 Ownership:
The information below is as of December 31, 2008.
(a) Amount beneficially owned:
1. Jayhawk Private Equity Fund, L.P.: 1,458,700 *
2. Jayhawk Private Equity Co-Invest Fund, L.P.: 91,842 **
3. Jayhawk Private Equity GP, L.P.: 1,550,542 ***
4. Jayhawk Capital Management, L.L.C.: 1,550,542 ***
5. Kent C. McCarthy: 1,550,542 ***
(b) Percent of class:
1. Jayhawk Private Equity Fund, L.P.: 6.7%
2. Jayhawk Private Equity Co-Invest Fund, L.P.: 0.4%
3. Jayhawk Private Equity GP, L.P.: 7.1%***
4. Jayhawk Capital Management, L.L.C.: 7.1%***
5. Kent C. McCarthy: 7.1%***
Percent of class is based on 21,434,942 outstanding shares of common stock, par
value $0.0001 per share, as reported by China Biologic Products, Inc. on its
Form 10-Q for the period ended September 30, 2008 filed with the Securities and
Exchange Commission on November 12, 2008.
(c) Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
1. Jayhawk Private Equity Fund, L.P.: 0
2. Jayhawk Private Equity Co-Invest Fund, L.P.: 0
3. Jayhawk Private Equity GP, L.P.: 0
4. Jayhawk Capital Management, L.L.C.: 0
5. Kent C. McCarthy: 0
(ii) Shared power to vote or direct the vote:
1. Jayhawk Private Equity Fund, L.P.: 1,458,700 *
2. Jayhawk Private Equity Co-Invest Fund, L.P.: 91,842 **
3. Jayhawk Private Equity GP, L.P.: 1,550,542 ***
4. Jayhawk Capital Management, L.L.C.: 1,550,542 ***
5. Kent C. McCarthy: 1,550,542 ***
(iii) Sole power to dispose or to direct the disposition of:
1. Jayhawk Private Equity Fund, L.P.: 0
2. Jayhawk Private Equity Co-Invest Fund, L.P.: 0
3. Jayhawk Private Equity GP, L.P.: 0
4. Jayhawk Capital Management, L.L.C.: 0
5. Kent C. McCarthy: 0
(iv) Shared power to dispose or to direct the disposition of:
1. Jayhawk Private Equity Fund, L.P.: 1,458,700 *
2. Jayhawk Private Equity Co-Invest Fund, L.P.: 91,842 **
3. Jayhawk Private Equity GP, L.P.: 1,550,542 ***
4. Jayhawk Capital Management, L.L.C.: 1,550,542 ***
5. Kent C. McCarthy: 1,550,542 ***
6
* Includes 1,010,581 shares of common stock, par value $0.001 per share, and
448,119 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report.
** Includes 63,628 shares of common stock, par value $0.001 per share, and
28,214 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report.
*** Includes 1,010,581 shares of common stock, par value $0.001 per share, and
448,119 warrants to purchase common stock that are exercisable within 60 days of
the filing of this report held by the Jayhawk Private Equity Fund, L.P. and
63,628 shares of common stock, par value $0.001 per share, and 28,214 warrants
to purchase common stock that are exercisable within 60 days of the filing of
this report held by the Jayhawk Private Equity Co-Invest Fund, L.P.
Item 10 Certification:
By signing below each party certifies that, to the best of its
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or
effect.
7
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
the parties below certify that the information set forth in this statement is
true, complete and correct.
Dated: February 13, 2009
/s/ Kent C. McCarthy
------------------------------------------
Kent C. McCarthy
Jayhawk Capital Management, L.L.C.
By: /s/ Kent C. McCarthy
---------------------------------------------
Name: Kent McCarthy
Title: Managing Member
Jayhawk Private Equity GP, L.P.
By: Jayhawk Capital Management, L.L.C.,
Its general partner
By: /s/ Kent C. McCarthy
------------------------------------
Name: Kent McCarthy
Title: Managing Member
Jayhawk Private Equity Fund, L.P.
By: Jayhawk Private Equity GP, L.P.
Its general partner
By: /s/ Kent C. McCarthy
------------------------------------
Name: Kent McCarthy
Title: Managing Member of Jayhawk
Capital Management, LLC, the General
Partner of Jayhawk Private Equity GP, L.P.
Jayhawk Private Equity Co-Invest Fund, L.P.
By: Jayhawk Private Equity GP, L.P.
Its general partner
By: /s/ Kent C. McCarthy
------------------------------------
Name: Kent McCarthy
Title: Managing Member of Jayhawk
Capital Management, LLC, the General
Partner of Jayhawk Private Equity GP, L.P.
8
Exhibit A
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13G
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934,
as amended, the undersigned agree to the joint filing on behalf of each of them
of a statement on Schedule 13G (including amendments thereto) with respect to
the Common Stock, par value $0.001 per share, of China Biologic Products, Inc.,
and further agree that this Agreement be included as an exhibit to such filings.
In evidence whereof, the undersigned have caused this Agreement to be
executed on their behalf this 13th day of February, 2009.
/s/ Kent C. McCarthy
--------------------------------------
Kent C. McCarthy
Jayhawk Capital Management, L.L.C.
By: /s/ Kent C. McCarthy
-----------------------------------
Name: Kent C. McCarthy
Title: Managing Member
Jayhawk Private Equity GP, L.P.
By: Jayhawk Capital Management, L.L.C.,
Its general partner
By: /s/ Kent C. McCarthy
--------------------------
Name: Kent C. McCarthy
Title: Managing Member
Jayhawk Private Equity Fund, L.P.
By: Jayhawk Private Equity GP, L.P.
Its general partner
By: /s/ Kent C. McCarthy
------------------------------------
Name: Kent C. McCarthy
Title: Managing Member of Jayhawk
Capital Management, LLC, the General
Partner of Jayhawk Private Equity GP, L.P.
Jayhawk Private Equity Co-Invest Fund, L.P.
By: Jayhawk Private Equity GP, L.P.
Its general partner
By: /s/ Kent C. McCarthy
------------------------------------
Name: Kent C. McCarthy
Title: Managing Member of Jayhawk
Capital Management, LLC, the General
Partner of Jayhawk Private Equity GP, L.P.